Category : Search result: coffee output FY26


US Lifts Tariffs on Indian Tea, Coffee & Spices

India to gain modestly as US removes reciprocal tariffs on agricultural products including tea, coffee and spices. Experts say benefits may be limited without infrastructure upgrades.

Supreme Power Equipment Q1 Net Profit Surges 32%

Supreme Power Equipment reports stellar H1 FY26 results with 29% revenue growth and 32% net profit increase. Strong performance driven by robust order book and operational excellence.

Kenya's Top Export Shifts From Coffee to Labour

Kenya's key export has transformed from coffee to human labour, revealing President Ruto's contrasting approach to workers. Discover how this shift reflects changing economic priorities.

Trump Reduces Tariffs on Indian Food Products

Former President Donald Trump announces significant tariff reductions on Indian agricultural exports including beef, coffee, and processed foods, boosting trade relations.

Hindustan Copper Q2 profit jumps 85% to ₹186 crore

State-owned Hindustan Copper reports impressive 85% surge in Q2 FY26 net profit reaching ₹186.02 crore, driven by robust income growth. Discover the key financial highlights and operational insights.

Standard Glass Lining Stock Gains 3.2%

Standard Glass Lining stock surged 3.2% as Indian markets extended gains. The company's Q2 FY26 profit rose 8.5% to ₹8.68 crore. Read more for key insights.

Subex Q2 FY26: Revenue Rises, Profit Declines 78%

Subex Limited reports mixed Q2 FY26 results with revenue growth of 3.78% YoY to ₹6,891 lakhs but profit after tax plunges 78%. Normalized EBITDA shows operational improvement. Read full analysis.

Coffee & Heart: Why One Cup Daily is Safe

A young patient's heart palpitations from black coffee highlight new research. A recent study reveals one daily cup may protect against irregular heartbeats. Learn the safe limits.

Mitsu Chem Plast Q2 Profit Jumps 66%

Mitsu Chem Plast Limited reports outstanding Q2 FY26 results with 66% net profit growth and 11% revenue increase, showcasing robust financial health and operational excellence.

Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook

Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.

Page 1 of 4